Practical oncoplastic surgery techniques needed for practice.

Oncoplastic breast surgery (OPS) is a form of breast conservation surgery that includes immediate breast reconstruction. OPS has previously been shown to be a safe and effective treatment for breast cancer. In a special series on Breast Reconstruction, we aimed to describe oncoplastic breast reconstruction options and the corresponding technical details. Sections were divided by descriptions of OPS specific preoperative workup, volume displacement techniques, volume replacement techniques, and postoperative considerations. In addition, to sharing expert surgical pearls gained through performing OPS procedures over the years. Innovations in breast reconstruction offer women treatment options that are both oncologically safe and aesthetically preferred. The rise in reconstructive procedures is changing how patients make decisions based on their diagnosis. The ultimate surgical decision should be determined by the patient's anatomy, patient's personal preferences, tumor characteristics, and clinical presentation in a shared decision-making fashion with a multidisciplinary team. However, with both volume displacement and volume replacement techniques, women of all breast sizes can achieve an aesthetic outcome without sacrificing oncologic resection.

Informations de copyright

2023 Annals of Translational Medicine. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-23-1536/coif). The series “Breast Reconstruction” was commissioned by the editorial office without any funding or sponsorship. SMN received payments from Dilon Technologies, honoraria and support from American Society of Breast Surgeons, American College of Osteopathic Surgeons, and owns stock of Cassava Sciences. Abhishek Chatterjee received payments from 3M, Dilon Technologies, Molynlcke, DeRoyal, Hologic, support from American Society of Breast Surgeons and American College of Osteopathic Surgeons, and holds stock of Dilon. The authors have no other conflicts of interest to declare.